A PK Study Testing Single Oral Dose of Elacestrant in Subjects With Normal or Severely Impaired Hepatic Function
Clinical trial NCT06126575 · COMPLETED
Trial details
- NCT number
- NCT06126575
- Sponsor
- Stemline Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-13
- Primary completion
- 2024-11-11
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.